Advertisement

Index by Author

December 1999; 48 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Akimoto, Y

    • Localization of the O-linked N-acetylglucosamine transferase in rat pancreas. Diabetes December 1999 48:2407-2413; doi:10.2337/diabetes.48.12.2407

  2. Alber, S M

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  3. Allen, L I

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  4. Ammälä, C

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  5. Antonelli, A

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  6. Ayres, S

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

B

  1. Bapat, S

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  2. Bavdekar, A

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  3. Bendtzen, K

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  4. Bhave, S

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  5. Biden, T J

    • Increases in phosphorylation of the myosin II heavy chain, but not regulatory light chains, correlate with insulin secretion in rat pancreatic islets and RINm5F cells. Diabetes December 1999 48:2383-2389; doi:10.2337/diabetes.48.12.2383

  6. Blaauwgeers, H G

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  7. Bonner-Weir, S

    • Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes December 1999 48:2270-2276; doi:10.2337/diabetes.48.12.2270

  8. Buchanan, T A

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

C

  1. Chang, T I

    • Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes December 1999 48:2454-2462; doi:10.2337/diabetes.48.12.2454

  2. Chapman, J C

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  3. Colvin, R B

    • A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes December 1999 48:2340-2348; doi:10.2337/diabetes.48.12.2340

  4. Conget, I

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  5. Cosgrove, K E

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

D

  1. Deckert, M

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  2. Deshpande, V

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  3. Dong, X

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  4. Dunne, M J

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

E

  1. Egan, J M

    • Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes December 1999 48:2358-2366; doi:10.2337/diabetes.48.12.2358

  2. Ellard, S

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  3. Evans, J C

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

F

  1. Fakhrai-Rad, H

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

  2. Fall, C H

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  3. Federici, M

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  4. Feili-Hariri, M

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  5. Ferrannini, E

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  6. Fine, E L

    • Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes December 1999 48:2454-2462; doi:10.2337/diabetes.48.12.2454

  7. Flatt, P R

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  8. Fortin, G

    • Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes December 1999 48:2454-2462; doi:10.2337/diabetes.48.12.2454

  9. Frayling, T M

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  10. Friedman, T

    • A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes December 1999 48:2340-2348; doi:10.2337/diabetes.48.12.2340

  11. Fujitani, Y

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  12. Furukawa, H

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

G

  1. Galli, J

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

  2. Giaccari, A

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  3. Giannini, S

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  4. Giesberts, A N

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  5. Gilon, P

    • Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. Diabetes December 1999 48:2374-2382; doi:10.2337/diabetes.48.12.2374

  6. Giovannone, B

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  7. Gomis, R

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

H

  1. Habener, J F

    • Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes December 1999 48:2270-2276; doi:10.2337/diabetes.48.12.2270

  2. Hamilton, J A

    • How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes December 1999 48:2255-2269; doi:10.2337/diabetes.48.12.2255

  3. Hanafusa, T

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  4. Hart, G W

    • Localization of the O-linked N-acetylglucosamine transferase in rat pancreas. Diabetes December 1999 48:2407-2413; doi:10.2337/diabetes.48.12.2407

  5. Hashmi, M N

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  6. Hattersley, A T

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  7. Henquin, J C

    • Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. Diabetes December 1999 48:2374-2382; doi:10.2337/diabetes.48.12.2374

  8. Hidaka, S

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  9. Himeno, K

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  10. Hirano, H

    • Localization of the O-linked N-acetylglucosamine transferase in rat pancreas. Diabetes December 1999 48:2407-2413; doi:10.2337/diabetes.48.12.2407

  11. Hitman, G A

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  12. Horal, M

    • Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes December 1999 48:2454-2462; doi:10.2337/diabetes.48.12.2454

  13. Hori, M

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  14. Hribal, M L

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

I

  1. Iacomini, J

    • A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes December 1999 48:2340-2348; doi:10.2337/diabetes.48.12.2340

  2. Inverardi, L

    • Effects of graft-versus-host reaction on intrahepatic islet transplants. Diabetes December 1999 48:2292-2299; doi:10.2337/diabetes.48.12.2292

  3. Ishida, H

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  4. Itateyama, E

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

J

  1. Jager, A

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  2. Joglekar, C

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

K

  1. Kajimoto, Y

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  2. Kamel, A

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

  3. Kamp, F

    • How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes December 1999 48:2255-2269; doi:10.2337/diabetes.48.12.2255

  4. Kaneto, H

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  5. Karlsen, A E

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  6. Kashiwagi, A

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  7. Kellingray, S D

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  8. Kikkawa, R

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  9. Kjos, S L

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

  10. Kondou, S

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  11. Kreppel, L K

    • Localization of the O-linked N-acetylglucosamine transferase in rat pancreas. Diabetes December 1999 48:2407-2413; doi:10.2337/diabetes.48.12.2407

  12. Kruszynska, Y T

    • A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes December 1999 48:2414-2421; doi:10.2337/diabetes.48.12.2414

  13. Kurokawa, M

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

L

  1. Lauro, D

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  2. Lauro, R

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  3. Lee, W P

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

  4. Ligtvoet, N

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  5. Li, H

    • Effects of graft-versus-host reaction on intrahepatic islet transplants. Diabetes December 1999 48:2292-2299; doi:10.2337/diabetes.48.12.2292

  6. Loeken, M R

    • Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes December 1999 48:2454-2462; doi:10.2337/diabetes.48.12.2454

  7. Lombardo, D

    • Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes December 1999 48:2316-2323; doi:10.2337/diabetes.48.12.2316

  8. Ludowyke, R I

    • Increases in phosphorylation of the myosin II heavy chain, but not regulatory light chains, correlate with insulin secretion in rat pancreatic islets and RINm5F cells. Diabetes December 1999 48:2383-2389; doi:10.2337/diabetes.48.12.2383

  9. Lupi, R

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  10. Luthman, H

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

  11. Lynn, S

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

M

  1. Madsen, O D

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  2. Malavasi, F

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  3. Mandrup-Poulsen, T

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  4. Marchetti, P

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  5. Marcus, C

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

  6. Masada, M

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  7. Mas, E

    • Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes December 1999 48:2316-2323; doi:10.2337/diabetes.48.12.2316

  8. Matsuoka, T

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  9. Matsushima, S

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  10. Matsuzawa, Y

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  11. McCarthy, M I

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  12. McClenaghan, N H

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  13. Meroni, P L

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  14. Millauer, B

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  15. Miyagawa, J

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  16. Möller, C

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  17. Morel, P A

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  18. Morviducci, L

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  19. Mulford, M I

    • A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes December 1999 48:2414-2421; doi:10.2337/diabetes.48.12.2414

N

  1. Nadal, A

    • Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes December 1999 48:2390-2397; doi:10.2337/diabetes.48.12.2390

  2. Nagamatsu, S

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  3. Nakamichi, Y

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  4. Nerup, J

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  5. Nicoletti, F

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  6. Nielsen, K

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  7. Nishio, Y

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  8. Norgren, S

    • Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes December 1999 48:2463-2470; doi:10.2337/diabetes.48.12.2463

O

  1. Okamoto, H

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  2. Okamura, T

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  3. Olefsky, J M

    • A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes December 1999 48:2414-2421; doi:10.2337/diabetes.48.12.2414

  4. Onaya, T

    • A transcriptional repressor regulates mouse GLUT4 gene expression during the differentiation of 3T3-L1 cells. Diabetes December 1999 48:2471-2474; doi:10.2337/diabetes.48.12.2471

  5. Ozawa, S

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

P

  1. Pandit, A N

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  2. Panicot, L

    • Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes December 1999 48:2316-2323; doi:10.2337/diabetes.48.12.2316

  3. Parving, H H

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  4. Pastore, L

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  5. Peters, R K

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

  6. Pineyro, M A

    • Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes December 1999 48:2358-2366; doi:10.2337/diabetes.48.12.2358

  7. Pupilli, C

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

Q

  1. Quesada, I

    • Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes December 1999 48:2390-2397; doi:10.2337/diabetes.48.12.2390

R

  1. Ravier, M A

    • Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. Diabetes December 1999 48:2374-2382; doi:10.2337/diabetes.48.12.2374

  2. Ricordi, C

    • Effects of graft-versus-host reaction on intrahepatic islet transplants. Diabetes December 1999 48:2292-2299; doi:10.2337/diabetes.48.12.2292

S

  1. Sakata, T

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  2. Salter, R D

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  3. Sampson, M J

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  4. Sandler, S

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  5. Schalkwijk, C G

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  6. Schlingemann, R O

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  7. Serup, P

    • Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes December 1999 48:2324-2332; doi:10.2337/diabetes.48.12.2324

  8. Sesti, G

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  9. Shepherd, R M

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  10. Shinozaki, K

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  11. Smith, R N

    • A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes December 1999 48:2340-2348; doi:10.2337/diabetes.48.12.2340

  12. Soria, B

    • Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes December 1999 48:2390-2397; doi:10.2337/diabetes.48.12.2390

  13. Stehouwer, C D

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  14. Stoffers, D A

    • Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes December 1999 48:2270-2276; doi:10.2337/diabetes.48.12.2270

T

  1. Tajima, D

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  2. Takasawa, S

    • Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes December 1999 48:2309-2315; doi:10.2337/diabetes.48.12.2309

  3. Tamburrano, G

    • Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly. Diabetes December 1999 48:2277-2285; doi:10.2337/diabetes.48.12.2277

  4. Tarnow, L

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

  5. Tawata, M

    • A transcriptional repressor regulates mouse GLUT4 gene expression during the differentiation of 3T3-L1 cells. Diabetes December 1999 48:2471-2474; doi:10.2337/diabetes.48.12.2471

  6. Thivolet, C

    • Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes December 1999 48:2316-2323; doi:10.2337/diabetes.48.12.2316

  7. Toda, N

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  8. Trepicchio, W

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  9. Trigo, E

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

  10. Turner, C

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  11. Turner, R C

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  12. Twaalfhoven, H

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

U

  1. Umayahara, Y

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

V

  1. van Hinsbergh, V W

    • Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes December 1999 48:2446-2453; doi:10.2337/diabetes.48.12.2446

W

  1. Walker, M

    • Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes December 1999 48:2475-2479; doi:10.2337/diabetes.48.12.2475

  2. Wang, X

    • Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes December 1999 48:2358-2366; doi:10.2337/diabetes.48.12.2358

  3. Watanabe, T

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  4. Watkins, S C

    • Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes December 1999 48:2300-2308; doi:10.2337/diabetes.48.12.2300

  5. White, S J

    • ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes December 1999 48:2349-2357; doi:10.2337/diabetes.48.12.2349

  6. Wilson, J R

    • Increases in phosphorylation of the myosin II heavy chain, but not regulatory light chains, correlate with insulin secretion in rat pancreatic islets and RINm5F cells. Diabetes December 1999 48:2383-2389; doi:10.2337/diabetes.48.12.2383

X

  1. Xiang, A H

    • Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes December 1999 48:2430-2436; doi:10.2337/diabetes.48.12.2430

  2. Xu, G

    • Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes December 1999 48:2270-2276; doi:10.2337/diabetes.48.12.2270

Y

  1. Yajnik, C S

    • Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes December 1999 48:2422-2429; doi:10.2337/diabetes.48.12.2422

  2. Yamamura, C

    • Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes December 1999 48:2367-2373; doi:10.2337/diabetes.48.12.2367

  3. Yamasaki, Y

    • Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes December 1999 48:2398-2406; doi:10.2337/diabetes.48.12.2398

  4. Yokomori, N

    • A transcriptional repressor regulates mouse GLUT4 gene expression during the differentiation of 3T3-L1 cells. Diabetes December 1999 48:2471-2474; doi:10.2337/diabetes.48.12.2471

  5. Yoshida, Y

    • Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes December 1999 48:2437-2445; doi:10.2337/diabetes.48.12.2437

  6. Yoshimatsu, H

    • Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes December 1999 48:2286-2291; doi:10.2337/diabetes.48.12.2286

  7. Yu, J G

    • A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes December 1999 48:2414-2421; doi:10.2337/diabetes.48.12.2414

Z

  1. Zaccone, P

    • Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes December 1999 48:2333-2339; doi:10.2337/diabetes.48.12.2333

  2. Zhou, J

    • Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes December 1999 48:2358-2366; doi:10.2337/diabetes.48.12.2358

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement